Hu Edward H
Wolfe Eye Clinic, Hiawatha, IA, USA.
Clin Ophthalmol. 2023 Dec 23;17:4001-4007. doi: 10.2147/OPTH.S441524. eCollection 2023.
To determine the incidence of postoperative repositioning of toric intraocular lenses (IOLs) due to clinically significant rotation.
This study included consecutive cataract patients with pre-existing astigmatism who had undergone cataract surgery with toric IOL implantation by a single experienced surgeon. Case records of patients who were recommended to undergo toric IOL repositioning surgery due to clinically significant postoperative IOL rotation from the implanted axis were identified. The need for a secondary intervention to manage residual astigmatism was based upon postoperative residual astigmatic error ≥0.75 D, the patient's qualitative dissatisfaction with the level of postoperative distance vision, dilated post-op examination, and confirmation of the significant potential for astigmatism reduction.
Case records of 993 eyes implanted with AcrySof toric (N = 362), Tecnis Toric I (N = 53), Tecnis Toric II (N = 308), or enVista Toric IOLs (N = 270) were included. Postoperative toric IOL repositioning was recommended in 16 eyes (1.6%). The repositioning rate was highest in the eyes implanted with Tecnis Toric I (5.7%), followed by AcrySof Toric (2.2%), enVista Toric IOLs (1.1%), and Tecnis Toric II (0.6%).
This real-world analysis of eyes implanted with toric IOLs revealed that the rate of surgical IOL repositioning due to clinically significant IOL rotation was lower than 2% for enVista and Tecnis Toric II IOLs. When needed and with appropriate planning, toric IOL repositioning can be very successful.
确定因具有临床意义的旋转而导致的散光型人工晶状体(IOL)术后重新定位的发生率。
本研究纳入了患有散光且连续接受白内障手术并由同一位经验丰富的外科医生植入散光型IOL的白内障患者。识别出因术后IOL从植入轴发生具有临床意义的旋转而被建议接受散光型IOL重新定位手术的患者病历。对残余散光进行二次干预的必要性基于术后残余散光误差≥0.75 D、患者对术后远视力水平的定性不满、术后散瞳检查以及证实散光有显著降低潜力。
纳入了993只植入了AcrySof散光型(N = 362)、Tecnis散光型I(N = 53)、Tecnis散光型II(N = 308)或enVista散光型IOL(N = 270)的眼睛的病历。16只眼(1.6%)被建议进行术后散光型IOL重新定位。植入Tecnis散光型I的眼睛重新定位率最高(5.7%),其次是AcrySof散光型(2.2%)、enVista散光型IOL(1.1%)和Tecnis散光型II(0.6%)。
这项对植入散光型IOL的眼睛的真实世界分析表明,对于enVista和Tecnis散光型II IOL,因具有临床意义的IOL旋转而进行手术IOL重新定位的发生率低于2%。如有需要并进行适当规划,散光型IOL重新定位可以非常成功。